Schedule 13G ownership disclosure

IMPEL NEUROPHARMA INC

Security class unavailable · CUSIP: 45258K109

Event date: 2021-04-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,309,791
Percent of class
11.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-063099
Form type
SC 13G
Filer
5AM Ventures V, L.P.
CIK
CIK 1674324
Filed
May 07, 2021
Reporting period
Apr 27, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub